One year of qualification
Audited Supplier
In This Store
![4,5-dihydro-N-[(2-methylphenyl)methyl]-1H-Imidazol-2-amine](https://eimg.pharmasources.com/image/20230627/51NSpcxd0G7sinJFyfrPEyNTxRDSd5uE8CXRGEJ8.gif!200)
Shenzhen Tianyuan Pharmaceutical Technology Co., Ltd. is an international enterprise engaged in the R&D and production of pharmaceutical ingredients and intermediates. The company has established a multi-functional R&D center in Shenzhen Zhongcheng Biomedical Industrial Park, which has a group of innovative drugs and generic drugs technicians and 60 foreign trade professionals. We have personnel stationed abroad in Bangladesh, India, Pakistan, the United States, Croatia, Italy, Brazil, Uruguay, South Korea, Japan and other countries. We have established long-term good cooperative relations with well-known local pharmaceutical companies, and have a complete supply chain ofinnovative drugs and generic drugs.
Year of Establishment: 2009
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: 100-500
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages: Development and production ofkey intermediates for innovativeand generic drugs and generic drugs. API process development, Quality research, registration and declaration. Customization and production ofspecialty APIs. Development ofGreen chemical synthesis process.
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight JANUARY 2024
![1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoro](https://eimg.pharmasources.com/image/20230526/wvTdi2Ll9r3cQvtJLVsNaS0zB2x3KrzVYBHwg9PP.png!200)
